As innovators and investors, we live for the moments when two industry disruptors come together to redefine a market. Today is one of those moments. Cresilon Inc, a Brooklyn-based biotechnology company, has inked a distribution deal with Penn Veterinary Supply. The partnership aims to bring VETIGEL—a game-changing, plant-based hemostatic gel—directly to veterinarians, reshaping the veterinary care landscape and pet care industry.
Shaping the Future
Revolutionizing Hemostatic Solutions: Cresilon’s VETIGEL is not just another product; it's a pioneering agent. Initially launched in 2021, it has gained traction among licensed veterinarians in the U.S and U.K. With its instant bleeding control, VETIGEL has proven to be a significant upgrade over traditional methods.
